Prognostic Value of Two Polymorphisms, Rs1045642 and Rs1128503, in ABCB1 Following Taxane-based Chemotherapy: A Meta-Analysis

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2021 Jan 28

PMID 33507672

Citations 5

Authors

Quanyao Chen

Wanlong Lin

Jianhui Yang

Min Lin

Xiuxian Lin

Yiyin Weng

Yao Chen

Affiliations

Soon will be listed here.

Abstract

Objective: Genetic polymorphisms can influence the chemotherapeutic response; however, previous studies have produced conflicting results, and have failed to identify the most relevant polymorphisms for predicting the response to treatment in patients with cancer. The present meta-analysis was conducted to determine the correlation between two polymorphisms (rs1045642 and rs1128503) in ATP-binding cassette transporter B subfamily member 1 (ABCB1), which is associated with multidrug resistance, and the survival of patients treated with taxane-containing chemotherapy.

Methods: Several databases, including PubMed and Embase, were used to retrieve articles evaluating the association between the ABCB1 rs1045642 and rs1128503 polymorphisms and survival, published prior to August 2019. The meta-analysis was conducted using R software to determine the pooled hazard ratio (HR) and 95% confidence intervals (95% CIs).

Results: Fifteen studies involving 3320 patients were included in the meta-analysis. The effect of the rs1128503 polymorphism on progression-free survival remained significant in the heterozygote (HR 0.81; 95% CI: 0.67-0.98) and homozygote (HR 0.71; 95% CI: 0.58-0.88) models. The TT genotype rs1128503 was associated with better overall survival (HR 0.72; 95% CI: 0.53-0.97).

Conclusion: Carriers of the rs1128503 T allele of ABCB1 showed a survival benefit after taxane-containing chemotherapy.

Citing Articles

Computational Analysis of MDR1 Variants Predicts Effect on Cancer Cells via their Effect on mRNA Folding.

Gutman T, Tuller T PLoS Comput Biol. 2024; 20(12):e1012685.

PMID: 39724131 PMC: 11670953. DOI: 10.1371/journal.pcbi.1012685.

NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN).

Vargas-Aliaga A, De la Haba M, Contreras M, Morales Estevez C, Porras I, Cano M Front Pharmacol. 2024; 15:1352939.

PMID: 38469410 PMC: 10925634. DOI: 10.3389/fphar.2024.1352939.

Pharmacogenetic Approach for the Prevention of Rivaroxaban's ADRs: A Systematic Review and Meta-Analysis.

Mardi P, Abbasi B, Shafiee A, Afsharmoghaddam T Genet Res (Camb). 2023; 2023:6105320.

PMID: 37942082 PMC: 10630013. DOI: 10.1155/2023/6105320.

Supporting Machine Learning Model in the Treatment of Chronic Pain.

Visibelli A, Peruzzi L, Poli P, Scocca A, Carnevale S, Spiga O Biomedicines. 2023; 11(7).

PMID: 37509416 PMC: 10376077. DOI: 10.3390/biomedicines11071776.

Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.

Hjorth C, Damkier P, Stage T, Feddersen S, Hamilton-Dutoit S, Rorth M Breast Cancer Res Treat. 2022; 194(2):353-363.

PMID: 35501422 PMC: 9239972. DOI: 10.1007/s10549-022-06596-2.

References

Szczyrek M, Mlak R, Krawczyk P, Wojas-Krawczyk K, Powrozek T, Szudy-Szczyrek A . Polymorphisms of Genes Encoding Multidrug Resistance Proteins as a Predictive Factor for Second-Line Docetaxel Therapy in Advanced Non-small Cell Lung Cancer. Pathol Oncol Res. 2016; 23(3):607-614. PMC: 5487877. DOI: 10.1007/s12253-016-0156-4. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Hoffmeyer S, Burk O, von Richter O, Arnold H, Brockmoller J, Johne A . Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000; 97(7):3473-8. PMC: 16264. DOI: 10.1073/pnas.97.7.3473. View

Kim R, Leake B, Choo E, Dresser G, Kubba S, Schwarz U . Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001; 70(2):189-99. DOI: 10.1067/mcp.2001.117412. View

Auner V, Sehouli J, Oskay-Oezcelik G, Horvat R, Speiser P, Zeillinger R . ABC transporter gene expression in benign and malignant ovarian tissue. Gynecol Oncol. 2009; 117(2):198-201. DOI: 10.1016/j.ygyno.2009.10.077. View

Priyadarshini R, Raj G, Kayal S, Ramesh A, Shewade D . Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India. J Clin Pharm Ther. 2019; 44(2):188-196. DOI: 10.1111/jcpt.12797. View

De Iudicibus S, De Pellegrin A, Stocco G, Bartoli F, Bussani R, Decorti G . ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer. Anticancer Res. 2009; 28(6B):3921-8. View

Orina J, Calcagno A, Wu C, Varma S, Shih J, Lin M . Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database. Mol Cancer Ther. 2009; 8(7):2057-66. PMC: 2736804. DOI: 10.1158/1535-7163.MCT-09-0256. View

Genovese I, Ilari A, Assaraf Y, Fazi F, Colotti G . Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resist Updat. 2017; 32:23-46. DOI: 10.1016/j.drup.2017.10.003. View

10.

Li W, Zhang D, Du F, Xing X, Wu Y, Xiao D . 3435TT and 421CC genotypes were significantly associated with longer progression-free survival in Chinese breast cancer patients. Oncotarget. 2018; 8(67):111041-111052. PMC: 5762303. DOI: 10.18632/oncotarget.22201. View

11.

Chang H, Rha S, Jeung H, Im C, Ahn J, Kwon W . Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Ann Oncol. 2008; 20(2):272-7. DOI: 10.1093/annonc/mdn624. View

12.

Chang H, Rha S, Jeung H, Im C, Noh S, Kim J . Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol Rep. 2009; 23(1):271-8. View

13.

Dean M, Rzhetsky A, Allikmets R . The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 2001; 11(7):1156-66. DOI: 10.1101/gr.184901. View

14.

Gandara D, Kawaguchi T, Crowley J, Moon J, Furuse K, Kawahara M . Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. J Clin Oncol. 2009; 27(21):3540-6. PMC: 2717760. DOI: 10.1200/JCO.2008.20.8793. View

15.

Penson R, Oliva E, Skates S, Glyptis T, Fuller Jr A, Goodman A . Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples. Gynecol Oncol. 2004; 93(1):98-106. DOI: 10.1016/j.ygyno.2003.11.053. View

16.

Kim J, Kim J, Im S, Kim Y, Han H, Kim J . ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy. Oncology. 2012; 83(4):218-27. DOI: 10.1159/000341359. View

17.

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

18.

Jiang Q, Xu M, Liu Y, Chen Y, Feng J, Wang X . Influence of the ABCB1 polymorphisms on the response to Taxane-containing chemotherapy: a systematic review and meta-analysis. Cancer Chemother Pharmacol. 2017; 81(2):315-323. DOI: 10.1007/s00280-017-3496-1. View

19.

Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M . The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics. 2001; 11(4):293-8. DOI: 10.1097/00008571-200106000-00003. View

20.

Frittitta L, Ercolino T, Bozzali M, Argiolas A, Graci S, Santagati M . A cluster of three single nucleotide polymorphisms in the 3'-untranslated region of human glycoprotein PC-1 gene stabilizes PC-1 mRNA and is associated with increased PC-1 protein content and insulin resistance-related abnormalities. Diabetes. 2001; 50(8):1952-5. DOI: 10.2337/diabetes.50.8.1952. View